Cross-fund · 4 holders
RIGL
RIGEL PHARMACEUTICALS INC
CUSIP 766559702
4
Tracked holders
$104.0M
Aggregate value
3,240,824
Shares
4
Active funds
Funds holding RIGL
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $47.8M | — | +104,697 | +6.3% |
| Vanguard | Institutional | Q4 2025 | $44.5M | — | −4,715 | −0.5% |
| Millennium | Multi-Strategy | Q1 2026 | $7.1M | — | −167,050 | −38.7% |
| Citadel | Multi-Strategy | Q1 2026 | $4.6M | — | −73,020 | −30.2% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.